Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug. The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious [...]
Earlier this week Vaxcyte (PCVX) shared an update on its VAX-31 trial results, which are quite promising. The stock popped nearly 50% on the news, sending shares to an all-time high of $115/share. VAX-31 is the company’s pneumococcal conjugate vaccine. This disease can contribute to more serious illnesses such as pneumonia, meningitis, and various [...]
Taiwan Semiconductor Manufacturing Company (TSM) gave an update on its revenue performance for the month of July this Friday morning, which initially sent shares 3% higher. Since the market opened, though, they’ve stayed around even on the day. The chip manufacturer’s $7.9 billion in sales worked out to a 45% growth in revenue. This [...]
Eli Lilly & Co. (LLY) is up more than 8% so far Thursday morning after reporting second-quarter earnings that easily surpassed the Wall Street consensus. The company also raised its guidance for the full year. The drugmaker posted adjusted earnings per share of $3.92, well ahead of the $2.60 that was expected by analysts. [...]
CVS Health Corporation (CVS) is down 1% today, making it an 8% loss on the week so far. The company’s latest earnings painted another disappointing picture, this time, as the healthcare-benefits segment struggled. The company’s net income of $1.77 billion was quite a step back from $1.90 billion this time last year. This worked [...]
Shares of Walgreens Boots Alliance (WBA) are down 22% this week after taking a nosedive Thursday on the heels of a disappointing Q3 performance coupled with a downtrodden outlook. This is the lowest we’ve seen the stock in 27 years, and we don’t see light at the end of the tunnel. The company’s fiscal [...]
Sarepta Therapeutics (SRPT) announced late Thursday it had gained FDA approval for its treatment designed to target a rare genetic disease known as Duchenne muscular dystrophy (DMD). This condition causes progressive weakness, predominantly in boys, and is caused by a lack of key protein dystrophin. It has no known cure at this time. The [...]
As more and more college campuses become protest centers for the Israel and Palestine conflict, the CEO of Hims & Hers Health (HIMS) made comments that sent his stock down more than 10% last week. Andrew Dudum expressed support for those brave enough to speak out against Israel saying that he and many other [...]
Over the past few years, Royal Philips (PHG) has been battered and bruised amidst concerns surrounding its devices being recalled and the implications of a settlement. The uncertainty has led to the stock getting cut nearly in half since 2021 when these issues were first noted. Its breathing devices and ventilators were created with [...]
Yesterday, the Centers for Medicare & Medicaid Services (CMS) shared their plans for federal payments to Medicare Advantage plans, and Humana (HUM) has taken a hit on the news. The stock is down 15% so far Tuesday morning. CMS first disclosed these plans back in January. At the time, Humana warned that should the [...]
